Impatients NV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Impatients NV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11282
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Impatients NV (Impatients), doing business as myTomorrows is a provider of drugs development and diagnostic testing services. The company’s services include turnkey solutions, global distribution solutions, early access programs, uniform information on medical conditions, and drugs development facilities services. It also provides could benefit solutions, clinical trials, database information solutions, treatment data solutions, supply diagnostic testing facilities services, data collection and condition based API solutions, among others. Impatients offers lymphoma treatment, glioblastoma treatment, and liver cancer treatment solutions, among others. The company provides its services to its clients and customers across the Netherlands. Impatients is headquartered in Amsterdam, the Netherlands.

Impatients NV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Impatients NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Impatients NV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Impatients NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Impatients NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Impatients NV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Impatients NV, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
myTomorrows Raises USD10.5 Million in Venture Financing 10
MyTomorrows Raises USD5.6 Million in Venture Financing 11
Partnerships 12
myTomorrows Enters into Agreement with Spectrum Pharma 12
Kamada Partners with myTomorrows 13
myTomorrows Enters into Agreement with Hemispherx Biopharma 14
Hemispherx Biopharma Amends Agreement with myTomorrows 15
Treeway Enters into Collaboration Agreement with myTomorrows 16
Impatients NV – Key Competitors 17
Impatients NV – Key Employees 18
Impatients NV – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Impatients NV, Pharmaceuticals & Healthcare, Key Facts 2
Impatients NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Impatients NV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Impatients NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Impatients NV, Deals By Therapy Area, 2012 to YTD 2018 8
Impatients NV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
myTomorrows Raises USD10.5 Million in Venture Financing 10
MyTomorrows Raises USD5.6 Million in Venture Financing 11
myTomorrows Enters into Agreement with Spectrum Pharma 12
Kamada Partners with myTomorrows 13
myTomorrows Enters into Agreement with Hemispherx Biopharma 14
Hemispherx Biopharma Amends Agreement with myTomorrows 15
Treeway Enters into Collaboration Agreement with myTomorrows 16
Impatients NV, Key Competitors 17
Impatients NV, Key Employees 18
Impatients NV, Other Locations 19

List of Figures
Impatients NV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Impatients NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Impatients NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Impatients NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Impatients NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Impatients NV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Impatients NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Impatients NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Impatients NV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Moneysupermarket.com Group PLC (MONY):企業の財務・戦略的SWOT分析
    Moneysupermarket.com Group PLC (MONY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • IntegraGen SA (ALINT):製薬・医療:M&Aディール及び事業提携情報
    Summary IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology. The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis …
  • Ansaldo Energia SpA:企業の戦略的SWOT分析
    Ansaldo Energia SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Globeimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Globeimmune Inc (Globeimmune) is a biopharmaceutical company that develops therapeutic products for treatment of cancer and infectious diseases. The company provides products for infectious disease and oncology. It offers oncology products such as GI-4000, GI-6207 and GI-6301. Globeimmune pr …
  • Orica Ltd:企業の戦略・SWOT・財務分析
    Orica Ltd - Strategy, SWOT and Corporate Finance Report Summary Orica Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Nord Gold SE:戦略・SWOT・企業財務分析
    Nord Gold SE - Strategy, SWOT and Corporate Finance Report Summary Nord Gold SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Novo Nordisk A/S:戦略・SWOT・企業財務分析
    Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report Summary Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ricardo plc:戦略・SWOT・企業財務分析
    Ricardo plc - Strategy, SWOT and Corporate Finance Report Summary Ricardo plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • CommInsure:企業の戦略・SWOT・財務情報
    CommInsure - Strategy, SWOT and Corporate Finance Report Summary CommInsure - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • SIRVA Inc:企業の戦略・SWOT・財務情報
    SIRVA Inc - Strategy, SWOT and Corporate Finance Report Summary SIRVA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Nippon Steel & Sumitomo Metal Corporation:企業のM&A・事業提携・投資動向
    Nippon Steel & Sumitomo Metal Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nippon Steel & Sumitomo Metal Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • Distell Group Limited:戦略・SWOT・企業財務分析
    Distell Group Limited - Strategy, SWOT and Corporate Finance Report Summary Distell Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Chuang’s Consortium International Ltd:企業の戦略・SWOT・財務情報
    Chuang's Consortium International Ltd - Strategy, SWOT and Corporate Finance Report Summary Chuang's Consortium International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Grundfos Holding AS:企業の戦略的SWOT分析
    Grundfos Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Galp Energia SGPS SA (GALP):電力:M&Aディール及び事業提携情報
    Summary Galp Energia SGPS SA (Galp) is an integrated energy company. It explores for, develops and produces crude oil and natural gas, refines crude oil, and markets refined petroleum products. The company also conducts power generation, produces biodiesel and trades gas. It imports, transports and …
  • Intertek Group Plc (ITRK):石油・ガス:M&Aディール及び事業提携情報
    Summary Intertek Group Plc (Intertek) is a provider of quality and safety solutions to various businesses across the globe. It offers services such as testing, inspection, certification, auditing, advisory services, quality assurance, consulting, sourcing, hazardous substance testing, analytical ass …
  • Alleghany Corporation:企業の戦略・SWOT・財務情報
    Alleghany Corporation - Strategy, SWOT and Corporate Finance Report Summary Alleghany Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Wesfarmers Ltd (WES):企業の財務・戦略的SWOT分析
    Wesfarmers Ltd (WES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • British Columbia Investment Management Corp:企業の戦略的SWOT分析
    British Columbia Investment Management Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Primordial Genetics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Primordial Genetics Inc (Primordial Genetics) is a biotechnology company that provides genetic and synthetic biology solutions for protein engineering and microbial improvement. The company develops improved bacterial and yeast strains for commercial protein production and protein expression …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆